Filgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium)

非格司亭生物类似药（Pharmstandard/Masterclone/CJSC Generium）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium)
Drug Alias Name重组人粒细胞刺激因子（Pharmstandard/Masterclone/CJSC Generium）rhG-CSF (Pharmstandard/Masterclone/CJSC Generium)Recombinant human granulocyte macrophage colony stimulating factor (Pharmstandard/Masterclone/CJSC Generium)非格司亭生物仿制药（Pharmstandard/Masterclone/CJSC Generium）Neipomax +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2008/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCjsc GeneriumPharmstandardMasterclone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A